In conclusion, we found that the optimal program for preeclampsia screening in pregnant women before 37 weeks of gestation is PAPP-A + PLGF + MAP + UTPI, which is extremely valuable in the prediction of early-onset preeclampsia. Here, PAPPA is linked to preeclampsia.